10-Q Filing

GLUCOSE HEALTH, INC. CIK: 1420108 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001477932-14-004205`
Period End Date	20140630
Filing Date	20140812
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	bisu-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 44 Income Statement 56 Cash Flow Statement 37

Balance Sheet 44 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`Cash`	$472.00	USD	Point-in-time
Cash	`Cash`	$711.00	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	24.08M	shares	Point-in-time
Inventory	`InventoryNet`	$24.88K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	18.87M	shares	Point-in-time
Inventory	`InventoryNet`	$15.13K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	18.87M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$25.59K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.60K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	24.08M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$25.59K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.60K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$156.65K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$144.63K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$7.71K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$6.00K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.67K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$71.04K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$73.75K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$223.35K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$238.11K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$238.11K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$223.35K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 24,078,003 and 18,872,777 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively (1)	`CommonStockValue`	$18.87K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 24,078,003 and 18,872,777 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively (1)	`CommonStockValue`	$24.08K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$4.87M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$4.74M	USD	Point-in-time
Stock to be issued	`StockToBeIssued1`	$34.40K	USD	Point-in-time
Stock to be issued	`StockToBeIssued1`	$27.75K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-15.45K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-17.37K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.90M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.05M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-197.76K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-222.51K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.60K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$25.59K	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	$442.00	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	$489.00	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
COST OF REVENUES	`CostOfRevenue`	-	USD	1 Quarter
COST OF REVENUES	`CostOfRevenue`	-	USD	2 Qtrs
COST OF REVENUES	`CostOfRevenue`	$9.28K	USD	1 Quarter
COST OF REVENUES	`CostOfRevenue`	$10.28K	USD	2 Qtrs
GROSS LOSS	`GrossProfit`	-	USD	1 Quarter
GROSS LOSS	`GrossProfit`	-	USD	2 Qtrs
GROSS LOSS	`GrossProfit`	$-9.79K	USD	2 Qtrs
GROSS LOSS	`GrossProfit`	$-8.84K	USD	1 Quarter
Professional fees/stock based compensation	`SalariesAndWages`	$97.02K	USD	2 Qtrs
Professional fees/stock based compensation	`SalariesAndWages`	$282.22K	USD	1 Quarter
Professional fees/stock based compensation	`SalariesAndWages`	$465.48K	USD	2 Qtrs
Professional fees/stock based compensation	`SalariesAndWages`	$63.40K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.95K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.31K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$12.59K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.34K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$478.07K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$110.33K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$71.35K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$285.57K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-120.12K	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-80.19K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-285.57K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-478.07K	USD	2 Qtrs
Interest income (expense)	`InterestExpense`	$28.82K	USD	2 Qtrs
Interest income (expense)	`InterestExpense`	$59.07K	USD	1 Quarter
Interest income (expense)	`InterestExpense`	$102.26K	USD	2 Qtrs
Interest income (expense)	`InterestExpense`	$22.35K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-59.07K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-28.82K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-102.26K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-22.35K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-102.54K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-580.33K	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-148.94K	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-344.63K	USD	1 Quarter
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-344.63K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-580.33K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-148.94K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-102.54K	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.08M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	23.54M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	13.27M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	21.78M	shares	2 Qtrs
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	-	USD	1 Quarter
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.05	USD	2 Qtrs
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.03	USD	1 Quarter

Cash Flow Statement 37 line items

Line Item	Tag	Value	Unit	Period
Cancellation shares	`CancellationShares`	600,000.00	shares	2 Qtrs
Net loss	`NetIncomeLoss`	$-344.63K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-580.33K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-148.94K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-102.54K	USD	1 Quarter
Inventory write down	`InventoryWriteDown`	$7.97K	USD	2 Qtrs
Inventory write down	`InventoryWriteDown`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$41.11K	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$428.30K	USD	2 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-25.60K	USD	2 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-99.83K	USD	2 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$-1.78K	USD	2 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$43.90K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$15.24K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.08K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$91.70K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$482.14K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-57.24K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-98.19K	USD	2 Qtrs
Proceeds from notes and loans payable	`ProceedsFromNotesAndLoansPayable`	$-113.62K	USD	2 Qtrs
Proceeds from notes and loans payable	`ProceedsFromNotesAndLoansPayable`	$-57.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$113.62K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$57.00K	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-239.00	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.44K	USD	2 Qtrs
CASH - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
CASH - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$711.00	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$472.00	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$16.51K	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$55.95K	USD	2 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$30.00K	USD	2 Qtrs
Cancellation of 600,000 shares of common stock to settle liabilities	`CancellationOfSharesOfCommonStockToSettleLiabilities`	$21.00K	USD	2 Qtrs
Cancellation of 600,000 shares of common stock to settle liabilities	`CancellationOfSharesOfCommonStockToSettleLiabilities`	-	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	$6.38K	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	-	USD	2 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`AcquisitionOfIntellectualPropertyOfType2DefenseForCommonShares`	$225.00K	USD	2 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`AcquisitionOfIntellectualPropertyOfType2DefenseForCommonShares`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.